Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
J Dermatol Sci ; 45(1): 23-30, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17123788

RESUMEN

BACKGROUND: To understand the behavioral biology of Langerhans cells (LCs), we recently recorded time-lapse images of LCs in the knock-in mice expressing the I-Abeta chain tagged with the enhanced green fluorescence protein (EGFP). EGFP(+) LCs showed relatively limited motility in the steady state, whereas topical application of dinitrofluorobenzene (DNFB) markedly augmented a unique movement of dendrites characterized by rhythmic extension and retraction, termed dSEARCH, and triggered amoeba-like lateral migration of cell bodies. OBJECTIVE: To define underlying mechanisms by which hapten treatment alters LC behaviors. METHODS: The I-Abeta-EGFP mice received subcutaneous (s.c.) injection of recombinant IL-1alpha or TNFalpha (50 ng/animal) and dynamic behaviors of EGFP(+) LCs were recorded by time-lapse confocal microscopy at several time points to measure their dSEARCH activities and lateral migration. In a different set of experiments, IL-1 receptor antagonist (IL-1Ra) or soluble TNF receptor-2 (sTNFR2) (0.5 microg/animal) was s.c. injected into the ear skin 30 min before topical application of DNFB, and LC behaviors analyzed 30 h later. RESULTS: Local injection of IL-1alpha or TNFalpha induced significant, albeit modest, augmentation of both dSEARCH and lateral migration. Co-injection of TNFalpha and IL-1alpha further exacerbated motile activities in a synergistic manner by similar magnitudes observed after DNFB application. Conversely, DNFB-induced behavioral changes were inhibited completely by local injection of IL-1Ra or sTNFR2. CONCLUSION: IL-1 and TNFalpha serve as equally important mediators of hapten-induced alteration of LC behaviors. Motile activities of epidermal LCs are reprogrammed by selected cytokines known to be produced by keratinocytes under pathological conditions.


Asunto(s)
Movimiento Celular/fisiología , Haptenos/administración & dosificación , Interleucina-1alfa/fisiología , Células de Langerhans/efectos de los fármacos , Células de Langerhans/fisiología , Factor de Necrosis Tumoral alfa/fisiología , Administración Tópica , Animales , Movimiento Celular/efectos de los fármacos , Dinitrofluorobenceno/antagonistas & inhibidores , Dinitrofluorobenceno/farmacología , Sinergismo Farmacológico , Colorantes Fluorescentes , Proteínas Fluorescentes Verdes , Haptenos/farmacología , Antígenos de Histocompatibilidad Clase II/genética , Antígenos de Histocompatibilidad Clase II/metabolismo , Inyecciones Subcutáneas , Interleucina-1alfa/administración & dosificación , Interleucina-1alfa/antagonistas & inhibidores , Interleucina-1alfa/farmacología , Cinética , Ratones , Ratones Transgénicos , Proteínas Recombinantes/farmacología , Factores de Tiempo , Factor de Necrosis Tumoral alfa/administración & dosificación , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/farmacología
2.
J Invest Dermatol ; 97(3): 478-82, 1991 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1678766

RESUMEN

Lanthanides are rare earths, elements 55-71 in the periodic table, that are of interest in biologic systems as isomorphic competitors for calcium binding sites. Lanthanides were tested for their inhibitory influence on the Ca++/Mg(++)-dependent ATPase of epidermal langerhans cells in vitro, and on the immunologic function of Langerhans cells in vivo. The trivalent ions of lanthanides, lanthanum, and cerium completely inhibited the ATPase staining of Langerhans cells in vitro. When mice were sensitized with dinitrofluorobenzene on skin sites pretreated with topical lanthanum chloride, and challenged on untreated ear skin, a markedly reduced contact hypersensitivity response was observed. This hyporesponsiveness was found to be antigen specific, and could be passively transferred to naive syngeneic animals recipients by CD4-CD8+ spleen cells. These results suggest that inhibition of the epidermal Langerhans cell surface ATPase by application of topical lanthanum and the induction of antigen-specific immunologic tolerance may be related events.


Asunto(s)
Adenosina Trifosfatasas/antagonistas & inhibidores , Dermatitis por Contacto/etiología , Células de Langerhans/enzimología , Metales de Tierras Raras/farmacología , Animales , Antígenos de Diferenciación de Linfocitos T/análisis , Linfocitos T CD4-Positivos/fisiología , Antígenos CD8 , Dinitrofluorobenceno/antagonistas & inhibidores , Inmunización Pasiva , Metales de Tierras Raras/inmunología , Ratones , Ratones Endogámicos , Bazo/citología , Linfocitos T/inmunología
3.
Arch Dermatol ; 120(9): 1179-83, 1984 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6332577

RESUMEN

Cyclosporine is a new antilymphocytic, immunosuppressive agent currently being used primarily in experimental and human organ transplantation. The current study evaluated the effect of systemically administered cyclosporine on a cutaneous T-cell-mediated disorder by using the murine model of allergic contact dermatitis to dinitrofluorobenzene. Cyclosporine was found to significantly inhibit the ear swelling response, whether the drug was given during the early sensitization period or at the time of antigenic challenge to fully sensitized mice. This suppressive effect was reversible when mice were rechallenged with dinitrofluorobenzene 96 hours after the first challenge. Cyclosporine was not effective if given to sensitized animals as late as six hours after challenge. Lastly, the observed inhibition of the ear swelling response to cyclosporine closely paralleled a diminished degree of inflammation seen histopathologically.


Asunto(s)
Ciclosporinas/uso terapéutico , Dermatitis por Contacto/tratamiento farmacológico , Inmunosupresores/uso terapéutico , Animales , Ciclosporinas/farmacología , Dermatitis por Contacto/inmunología , Dermatitis por Contacto/patología , Dinitrofluorobenceno/antagonistas & inhibidores , Dinitrofluorobenceno/inmunología , Relación Dosis-Respuesta Inmunológica , Inmunidad Celular , Inmunosupresores/farmacología , Masculino , Ratones , Ratones Endogámicos BALB C , Linfocitos T/inmunología
4.
Life Sci ; 90(3-4): 147-53, 2012 Jan 16.
Artículo en Inglés | MEDLINE | ID: mdl-22075493

RESUMEN

AIMS: Recently, some studies reported that digestive tract disease is closely associated with atopic dermatitis (AD). Pyeongwee-San (KMP6) is a Korean medicine, which has come onto the drugstore for the treatment of digestive tract disease. The aim of the present study was to examine whether KMP6 could suppress 2,4-dinitrofluorobenzene (DNFB)-induced AD-like skin lesions in NC/Nga mice. MAIN METHODS: Mice were sensitized with DNFB by applying to shaved dorsal skin. At that time, the drugs or saline were orally administrated to DNFB-applied mice. KEY FINDINGS: The administration of KMP6 or glycyrrhizic acid (GL), a major component of KMP6, inhibited the scratching number in DNFB-induced AD model. The mRNA expressions of interleukin (IL)-4, interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and CCR3 were upregulated by DNFB sensitization, but the upregulated mRNA expressions were significantly reduced by the administration of KMP6 or GL. In addition, the levels of IgE, histamine, and IL-4 were significantly reduced by the administration of KMP6 or GL in serum of DNFB-induced AD model. However, the level of IFN-γ in serum was significantly increased by KMP6 or GL. KMP6 or GL also significantly inhibited the numbers of inflammatory cells, mast cells, and protein level of IL-4 in lesions of DNFB-induced AD model. Finally, KMP6 or GL significantly decreased the productions of IL-4, IFN-γ, and TNF-α in anti-CD3 plus anti-CD28 antibody-stimulated splenocytes. SIGNIFICANCE: KMP6 showed anti-atopic potential in this setting; hence we suggest it as a potential prospect for anti-atopic agent besides being just a medicine for the stomach and bowels.


Asunto(s)
Antialérgicos/uso terapéutico , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/prevención & control , Dinitrofluorobenceno/toxicidad , Extractos Vegetales/uso terapéutico , Animales , Antialérgicos/farmacología , Dermatitis Atópica/patología , Dinitrofluorobenceno/antagonistas & inhibidores , Masculino , Ratones , Ratones Endogámicos , Extractos Vegetales/farmacología
5.
Int Immunopharmacol ; 11(9): 1271-7, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21504802

RESUMEN

Atopic dermatitis (AD) is one of the most common skin diseases, and its incidence is increasing in industrialized countries. Furthermore, the epicutaneous application of a hapten, such as 2,4-dinitrofluorobenzene (DNFB), evokes an AD-like lesion in NC/Nga mice under specific pathogen-free (SPF) conditions. Rosmarinic acid (RA) is a secondary metabolite that is frequently found in herbs, and has anti-inflammatory, anti-oxidant, and anti-microbial effects. In this study, we studied whether RA is an effective treatment against DNFB-induced AD-like skin lesions in NC/Nga mice. RA at 1 or 5 µM was found to suppress the productions of interferon (IFN)-γ and interleukin (IL)-4 significantly by activated CD4(+) T cells. Furthermore, an intraperitoneal injection of RA at 10 or 50 mg/kg significantly inhibited skin lesion development and ear thickness and total serum IgE level increases in DNFB-treated NC/Nga mice. In addition, intraperitoneal administered RA at 10 or 50 mg/kg significantly inhibited the infiltrations of CD4(+) T, CD8(+) T, and mast cells into DNFB-induced skin lesions in NC/Nga mice. This study suggests that RA suppresses the development of AD-like dermatitis in DNFB-treated NC/Nga mice by reducing IFN-γ and IL-4 production by activated T cells and total serum IgE levels.


Asunto(s)
Cinamatos/farmacología , Depsidos/farmacología , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/inmunología , Dinitrofluorobenceno/antagonistas & inhibidores , Piel/efectos de los fármacos , Piel/inmunología , Animales , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/patología , Dinitrofluorobenceno/farmacología , Haptenos/farmacología , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Interferón gamma/antagonistas & inhibidores , Interferón gamma/metabolismo , Interleucina-4/antagonistas & inhibidores , Interleucina-4/inmunología , Interleucina-4/metabolismo , Activación de Linfocitos/efectos de los fármacos , Activación de Linfocitos/inmunología , Masculino , Mastocitos/inmunología , Mastocitos/metabolismo , Mastocitos/patología , Ratones , Piel/patología , Enfermedades de la Piel/inmunología , Enfermedades de la Piel/metabolismo , Enfermedades de la Piel/patología , Ácido Rosmarínico
6.
Biol Pharm Bull ; 30(8): 1468-71, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17666805

RESUMEN

Epicutaneously administered chemical antigens like 2,4-dinitrofluorobenzene (DNFB), evoke an atopic dermatitis (AD)-like dermatitis reaction in NC/Nga mice under specific pathogen free (SPF) conditions. Astragalus membranaceus (AM), is a popular herbal medicine used to treat allergic diseases in East Asia. In the present study, we examined whether AM suppress AD-like skin lesions in NC/Nga mice treated with DNFB under SPF conditions. Oral administration of AM to DNFB-treated NC/Nga mice was found to inhibit ear thickness increases and the skin lesions induced by DNFB. Moreover, IFN-gamma production by CD4(+) T cells from the lymph nodes of DNFB-treated NC/Nga mice was significantly inhibited by AM treatment, although levels of IL-4 and total IgE in serum were not. Study findings suggest that AM may suppress the development of AD-like dermatitis in DNFB-treated NC/Nga mice by reducing IFN-gamma production.


Asunto(s)
Astragalus propinquus/química , Dermatitis Atópica/prevención & control , Dinitrofluorobenceno/antagonistas & inhibidores , Dinitrofluorobenceno/toxicidad , Animales , Antiinflamatorios/farmacología , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/metabolismo , Citocinas/biosíntesis , Dermatitis Atópica/inducido químicamente , Oído Externo/patología , Ensayo de Inmunoadsorción Enzimática , Femenino , Inmunoglobulina E/sangre , Interferón gamma/biosíntesis , Interleucina-4/biosíntesis , Ratones , Ratones Endogámicos , Prednisolona/farmacología , Piel/patología
7.
Biol Pharm Bull ; 25(6): 809-12, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12081154

RESUMEN

Anti-allergic effects (types I and IV) of the 70% ethanol extract (CM-ext) obtained from Cnidii Monnieri Fructus (dried fruits of Cnidium monnieri) were investigated on 48 h homologous passive cutaneous anaphylaxis (PCA), 2, 4-dinitrofluorobenzene (DNFB)-induced contact dermatitis and picryl chloride (PC)-induced contact dermatitis in experimental animals. CM-ext showed inhibitory effects on these allergic models. Osthol isolated from CM-ext also had the inhibitory effects. These results suggested that Cnidii Monnieri Fructus might be useful as an agent for allergic diseases and that its anti-allergic effect was partially attributable to a coumarin derivative, osthol.


Asunto(s)
Antialérgicos/farmacología , Cnidium/química , Cumarinas/farmacología , Frutas/química , Animales , Antiinflamatorios no Esteroideos/farmacología , Cumarinas/química , Dermatitis por Contacto/patología , Dermatitis por Contacto/prevención & control , Dinitrofluorobenceno/antagonistas & inhibidores , Dinitrofluorobenceno/toxicidad , Difenhidramina/farmacología , Espectroscopía de Resonancia Magnética , Masculino , Ratones , Ratones Endogámicos ICR , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Cloruro de Picrilo/antagonistas & inhibidores , Cloruro de Picrilo/toxicidad , Extractos Vegetales/farmacología , Prednisolona/farmacología , Prurito/inducido químicamente , Ratas , Ratas Wistar , Piel/patología
9.
Acta bioquím. clín. latinoam ; Acta bioquím. clín. latinoam;22(3): 391-401, sept. 1988. ilus, tab
Artículo en Español | LILACS | ID: lil-68939

RESUMEN

Los grupos amino de la XOD (Xantina oxidasa) del hígado de rata son inhibidos por reactivos como el benzaldehído y el 2,4-dinitrofluorbenceno. Esta inhibición ocurre más rápidamente a elevados pH y es progresiva e irreveersible. Estos reactivos atacan grupos amino de la XOD, pero no se excluye que haya otros grupos que puedan ser bloqueados. Si se representa la inhibición en función de la unión con el benaldehído o 2,4-dinitrofluorbenceno, se observa que una fracción relativamente pequeña del total de grupos amino de la XOD es más reactiva a esta inhibició y que estos grupos amino se modifican por estos inhibidores. Los estudios de unión del benzaldehído sugieren dos clases de actividad enzimática, presentes en igual proporción, pero difieren en su sensibilidad frente al benzaldehído. Los parámetros cinéticos de la actividad residual de la XOD tratada con benzaldehído se asemejan a los de la enzima nativa, excepto el comprotamiento inhibitorio frente a altas concentraciones de sustrato


Asunto(s)
Benzaldehídos/antagonistas & inhibidores , Dinitrofluorobenceno/antagonistas & inhibidores , Inhibidores Enzimáticos , Hígado/enzimología , Técnicas In Vitro , Xantina Oxidasa/antagonistas & inhibidores
10.
Acta bioquím. clín. latinoam ; 22(3): 391-401, sept. 1988. ilus, Tab
Artículo en Español | BINACIS | ID: bin-29473

RESUMEN

Los grupos amino de la XOD (Xantina oxidasa) del hígado de rata son inhibidos por reactivos como el benzaldehído y el 2,4-dinitrofluorbenceno. Esta inhibición ocurre más rápidamente a elevados pH y es progresiva e irreveersible. Estos reactivos atacan grupos amino de la XOD, pero no se excluye que haya otros grupos que puedan ser bloqueados. Si se representa la inhibición en función de la unión con el benaldehído o 2,4-dinitrofluorbenceno, se observa que una fracción relativamente pequeña del total de grupos amino de la XOD es más reactiva a esta inhibició y que estos grupos amino se modifican por estos inhibidores. Los estudios de unión del benzaldehído sugieren dos clases de actividad enzimática, presentes en igual proporción, pero difieren en su sensibilidad frente al benzaldehído. Los parámetros cinéticos de la actividad residual de la XOD tratada con benzaldehído se asemejan a los de la enzima nativa, excepto el comprotamiento inhibitorio frente a altas concentraciones de sustrato (AU)


Asunto(s)
Técnicas In Vitro , Xantina Oxidasa/antagonistas & inhibidores , Inhibidores Enzimáticos , Dinitrofluorobenceno/antagonistas & inhibidores , Benzaldehídos/antagonistas & inhibidores , Hígado/enzimología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA